COMP <GO>
BAX vs GKOS // PIOTROSKI F-SCORE QUALITY
Baxter International Inc. (NYSE) VS. Glaukos Corporation (NYSE) • 15-METRIC TALLY: BAX 7
— GKOS 6
▲ PIOTROSKI F-SCORE QUALITY LEADER: BAX
LAST: $24.22 (+5.30%) • MKT CAP: $11.90B
piotroski-score
6/9
LAST: $238.61 (+0.43%) • MKT CAP: $14.07B
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BAX VS. GKOS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BAX | GKOS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.10% | 55.70% | -25.60 | GKOS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.40% | -13.70% | +11.30 | BAX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.79% | -0.16% | +2.95 | BAX | /fcf-yield <GO> |
| Operating Margin | -2.70% | -39.30% | +36.60 | BAX | /operating-margins <GO> |
| Net Profit Margin | -8.50% | -37.00% | +28.50 | BAX | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 32.30% | -26.60 | GKOS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.86% | 0.00% | +2.86 | BAX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 26.00 | -23.78 | GKOS | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | 5/9 | +1.00 | BAX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 78.7 | -39.70 | GKOS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 1.04 | -0.09 | GKOS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 34.0x | -16.00 | BAX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.90B | $14.07B | -$2.17B | GKOS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BAX REV | GKOS REV | BAX GROSS % | GKOS GROSS % | BAX FCF | GKOS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.24B | $507.4M | 30.1% | 55.7% | $339.0M | -$22.5M |
| FY 2024 | $10.64B | $383.5M | 37.5% | 75.5% | $540.4M | -$67.6M |
| FY 2023 | $10.36B | $314.7M | — | — | $1.26B | -$71.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BAX // BETA 0.95
GKOS // BETA 1.04